Skin Cancer

 

Tips&Tools

About
 Daily News from Top Searches
Popular Searches
Tips on Searching
SearchMedica for IPhone
Go To SearchMedica
Sign Up For Our Newsletter


SkinCancerNews

Single-Center Experience With Ipilimumab in an Expanded Access Program for Patients With Pretreated Advanced Melanoma
journals.lww.com - 4/1/13
imageIpilimumab, a CTLA-4-blocking monoclonal antibody, improved the overall survival (OS) of advanced melanoma patients treated in prospective clinical trials. We here report a study on the outcome of patients with pretreated advance
Molecular Cancer | Abstract | Timp1 interacts with beta-1 integrin and CD63 along melanoma genesis and confers anoikis resistance by activating PI3-K signaling pathway independently of Akt phosphorylation
www.molecular-cancer.com - 3/25/13
Anoikis resistance is one of the abilities acquired along tumor progression. This characteristic is associated with metastasis development, since tumorigenic cells must survive independently of cell-matrix interactions in this process. In our laboratory, it was developed a murine melanocyte malignant transformation model associated with a sustained stressful condition. After subjecting melan-a melanocytes to 1, 2, 3 and 4 cycles of anchorage impediment, anoikis resistant cells were established and named 1
Smoke's Genetic Impact Lingers
www.medpagetoday.com - 3/25/13
(MedPage Today) -- Smoking is linked to gene expression changes, some of which appear to persist after quitting, researchers found.

Result Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 Next



FeaturedArticles

May 15, 2013
Advances in the Systemic Treatment of Metastatic Melanoma
Within the relatively short time that ipilimumab and vemurafenib have been commercially available, phase II data for the investigational agents nivolumab and MK-3475, for the combination of dabrafenib and trametinib, and for adoptive cell therapy strongly suggest even further improvements in... More »
May 8, 2013
Vismodegib: Its Pros and Cons in Basal Cell Carcinoma
Experts offer an update on current research in hedgehog signaling pathway inhibition in basal cell carcinoma, including efficacy and toxicity results for vismodegib (Erivedge), the first oral medication to win FDA approval for metastatic BCC treatment. More »
May 7, 2013
Slide Show: Squamous Cell Carcinoma of the Head and Neck
A head and neck cancer slide show including a laryngectomy specimen, and poorly and moderately differentiated verrucous and keratinizing squamous cell carcinomas. More »
May 3, 2013
Malignant Melanoma In Situ
Eccentric darker pigmentation in this small asymptomatic lesion strongly suggests malignant melanoma. This patient had a history of non-melanoma skin cancer, but was unaware of the questionable growth. More »
March 25, 2013
Pigmented Basal Cell Carcinoma
The areas that contained linear erythema, punctuated by stippled pigmentation, and a small round area of stippled pigmentation were biopsied: both showed pigmented basal cell carcinoma. More »
Showing 1 - 5 of 136 results.
Page of 28
First Previous Last

PubMed

Surgery and the management of cutaneous melanoma.
pubmed.gov - 1/31/13
-Catulin downregulates E-cadherin and promotes melanoma progression and invasion.
pubmed.gov - 1/31/13
Metastatic melanoma from an unknown primary site presenting as skin-colored nodules and multiple visceral involvement.
pubmed.gov - 1/24/13
Spectrum of morphologic alterations of regression in cutaneous melanoma--potential for improving disease prognosis.
pubmed.gov - 1/17/13
SPECT/CT for sentinel lymph node detection in patients with melanoma--reply.
pubmed.gov - 1/15/13
More Results

ClinicalTrials

Single-Center Experience With Ipilimumab in an Expanded Access Program for Patients With Pretreated Advanced Melanoma
journals.lww.com - 4/1/13
Molecular Cancer | Abstract | Timp1 interacts with beta-1 integrin and CD63 along melanoma genesis and confers anoikis resistance by activating PI3-K signaling pathway independently of Akt phosphorylation
www.molecular-cancer.com - 3/25/13
A role for immunohistochemical detection of BRAF V600E prior to BRAF-inhibitor treatment of malignant melanoma?
jcp.bmj.com - 3/23/13
Molecular biology of normal melanocytes and melanoma cells
jcp.bmj.com - 3/23/13
Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50000 individuals : The Lancet
www.thelancet.com - 3/23/13
More Results


TopicIndex

PracticeGuidelines

Single-Center Experience With Ipilimumab in an Expanded Access Program for Patients With Pretreated Advanced Melanoma
journals.lww.com - 4/1/13
Molecular Cancer | Abstract | Timp1 interacts with beta-1 integrin and CD63 along melanoma genesis and confers anoikis resistance by activating PI3-K signaling pathway independently of Akt phosphorylation
www.molecular-cancer.com - 3/25/13
A role for immunohistochemical detection of BRAF V600E prior to BRAF-inhibitor treatment of malignant melanoma?
jcp.bmj.com - 3/23/13
Molecular biology of normal melanocytes and melanoma cells
jcp.bmj.com - 3/23/13
Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50000 individuals : The Lancet
www.thelancet.com - 3/23/13
Rahil Garnavi
researcher.watson.ibm.com - 3/22/13
More Results


FromPhysiciansPractice

Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 


PatientResources

American Cancer Society
Skin Cancer: Basal and Squamous Cell
Skin Cancer: Melanoma


National Cancer Institute
General Information About Skin Cancer

 

National Comprehensive Cancer Network
Guidelines for Patients - Melanoma